[Antiretroviral treatment and resistance].
Gómez-Cano
M
M
Servicio de Enfermedades Infecciosas, Centro de Investigaciones Clinicas, Instituto de Salud Carlos III, Madrid.
Villalba
N
N
Mas
A
A
Holguín
A
A
Soriano
V
V
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012192:Retroviridae Infections / Q000188:drug therapy*; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology; D015215:Zidovudine / Q000494:pharmacology
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine